We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, smart money investors have to conduct complex analyses, spend many resources and use tools that are not always available for the general crowd. This doesn't mean that they don't have occasional colossal losses; they do (like Melvin Capital's recent GameStop losses). However, it is still a good idea to keep an eye on hedge fund activity. With this in mind, as the current round of 13F filings has just ended, let’s examine the smart money sentiment towards vTv Therapeutics Inc (NASDAQ:VTVT).
Is vTv Therapeutics Inc (NASDAQ:VTVT) the right investment to pursue these days? Prominent investors were becoming more confident. The number of long hedge fund positions rose by 2 in recent months. vTv Therapeutics Inc (NASDAQ:VTVT) was in 5 hedge funds' portfolios at the end of the first quarter of 2021. The all time high for this statistic is 6. Our calculations also showed that VTVT isn't among the 30 most popular stocks among hedge funds (click for Q1 rankings).
Hedge funds' reputation as shrewd investors has been tarnished in the last decade as their hedged returns couldn't keep up with the unhedged returns of the market indices. Our research has shown that hedge funds' small-cap stock picks managed to beat the market by double digits annually between 1999 and 2016, but the margin of outperformance has been declining in recent years. Nevertheless, we were still able to identify in advance a select group of hedge fund holdings that outperformed the S&P 500 ETFs by 115 percentage points since March 2017 (see the details here). We were also able to identify in advance a select group of hedge fund holdings that underperformed the market by 10 percentage points annually between 2006 and 2017. Interestingly the margin of underperformance of these stocks has been increasing in recent years. Investors who are long the market and short these stocks would have returned more than 27% annually between 2015 and 2017. We have been tracking and sharing the list of these stocks since February 2017 in our quarterly newsletter.
Billionaire David Siegel's Top 10 Stock Picks
David Siegel of Two Sigma Advisors
At Insider Monkey, we scour multiple sources to uncover the next great investment idea. For example, an activist hedge fund owns nearly 40% of this $23 biotech stock and is trying to buy the rest for around $50. So, we recommended a long position to our monthly premium newsletter subscribers. We go through lists like the 10 best battery stocks to pick the next Tesla that will deliver a 10x return. Even though we recommend positions in only a tiny fraction of the companies we analyze, we check out as many stocks as we can. We read hedge fund investor letters and listen to stock pitches at hedge fund conferences. You can subscribe to our free daily newsletter on our homepage. Now let's take a look at the latest hedge fund action surrounding vTv Therapeutics Inc (NASDAQ:VTVT).
Do Hedge Funds Think VTVT Is A Good Stock To Buy Now?
At the end of the first quarter, a total of 5 of the hedge funds tracked by Insider Monkey were bullish on this stock, a change of 67% from the fourth quarter of 2020. Below, you can check out the change in hedge fund sentiment towards VTVT over the last 23 quarters. So, let's check out which hedge funds were among the top holders of the stock and which hedge funds were making big moves.
Is VTVT A Good Stock To Buy?
According to publicly available hedge fund and institutional investor holdings data compiled by Insider Monkey, John Overdeck and David Siegel's Two Sigma Advisors has the most valuable position in vTv Therapeutics Inc (NASDAQ:VTVT), worth close to $0.6 million, comprising less than 0.1%% of its total 13F portfolio. The second largest stake is held by Citadel Investment Group, managed by Ken Griffin, which holds a $0.5 million position; less than 0.1%% of its 13F portfolio is allocated to the stock. Remaining peers that hold long positions comprise Greg Eisner's Engineers Gate Manager, Cliff Asness's AQR Capital Management and Israel Englander's Millennium Management. In terms of the portfolio weights assigned to each position Engineers Gate Manager allocated the biggest weight to vTv Therapeutics Inc (NASDAQ:VTVT), around 0.0047% of its 13F portfolio. Two Sigma Advisors is also relatively very bullish on the stock, setting aside 0.0015 percent of its 13F equity portfolio to VTVT.
With a general bullishness amongst the heavyweights, some big names were breaking ground themselves. Citadel Investment Group, managed by Ken Griffin, created the biggest position in vTv Therapeutics Inc (NASDAQ:VTVT). Citadel Investment Group had $0.5 million invested in the company at the end of the quarter. Cliff Asness's AQR Capital Management also made a $0.1 million investment in the stock during the quarter. The only other fund with a brand new VTVT position is Israel Englander's Millennium Management.
Let's now review hedge fund activity in other stocks - not necessarily in the same industry as vTv Therapeutics Inc (NASDAQ:VTVT) but similarly valued. These stocks are Remark Holdings, Inc. (NASDAQ:MARK), National Bankshares Inc. (NASDAQ:NKSH), Ayro, Inc. (NASDAQ:AYRO), Corvus Gold Inc. (NASDAQ:KOR), Postal Realty Trust, Inc. (NYSE:PSTL), Mid Penn Bancorp (NASDAQ:MPB), and Genasys Inc. (NASDAQ:GNSS). This group of stocks' market valuations are closest to VTVT's market valuation.
[table] Ticker, No of HFs with positions, Total Value of HF Positions (x1000), Change in HF Position MARK,9,10743,3 NKSH,3,13677,1 AYRO,5,4043,2 KOR,2,41675,-1 PSTL,9,34785,1 MPB,4,4162,2 GNSS,7,21868,1 Average,5.6,18708,1.3 [/table]
As you can see these stocks had an average of 5.6 hedge funds with bullish positions and the average amount invested in these stocks was $19 million. That figure was $1 million in VTVT's case. Remark Holdings, Inc. (NASDAQ:MARK) is the most popular stock in this table. On the other hand Corvus Gold Inc. (NASDAQ:KOR) is the least popular one with only 2 bullish hedge fund positions. vTv Therapeutics Inc (NASDAQ:VTVT) is not the least popular stock in this group but hedge fund interest is still below average. Our overall hedge fund sentiment score for VTVT is 53.4. Stocks with higher number of hedge fund positions relative to other stocks as well as relative to their historical range receive a higher sentiment score. This is a slightly negative signal and we'd rather spend our time researching stocks that hedge funds are piling on. Our calculations showed that top 5 most popular stocks among hedge funds returned 95.8% in 2019 and 2020, and outperformed the S&P 500 ETF (SPY) by 40 percentage points. These stocks gained 17.4% in 2021 through June 18th and surpassed the market again by 6.1 percentage points. Unfortunately VTVT wasn't nearly as popular as these 5 stocks (hedge fund sentiment was quite bearish); VTVT investors were disappointed as the stock returned -13.5% since the end of March (through 6/18) and underperformed the market. If you are interested in investing in large cap stocks with huge upside potential, you should check out the top 5 most popular stocks among hedge funds as most of these stocks already outperformed the market in 2021.
Get real-time email alerts: Follow Vtv Therapeutics Inc. (NASDAQ:VTVT)
Disclosure: None. This article was originally published at Insider Monkey.
